Suven Pharmaceuticals, a contract development and manufacturing organisation (CDMO) player, has signed a deal to buy a 67.5% stake in Sapala Organics for Rs 229.5 crore ($27.5 million).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
